Adisyn has worldwide rights to commercialise graphene-based radar signature reduction technology.
The Market Online - At The Bell

Join our daily newsletter At The Bell to receive exclusive market insights

  • Exclusive, worldwide commercialisation rights secured for graphene-based radar absorption technology
  • Positions Adisyn in emerging stealth materials market
  • Investigating potential other usages in the defence sectors

Adisyn (ASX:AI1) has entered into a binding licence and research agreement with Tel Aviv University to commercialise graphene-based radar signature reduction technology.

Listen to the HotCopper podcast for in-depth discussions and insights on all the biggest headlines from throughout the week. On Spotify, Apple, and more.

The agreement comes at a time of increasing global focus on radar signature management, driven by the rapid expansion of UAV deployment, loitering munitions and the growing sophistication of detection systems across defence and aerospace sectors.

The agreement between Adisyn subsidiary 2D Radar Absorbers and the university’s technology transfer company, Ramot, grants Adisyn exclusive, worldwide rights to commercialise graphene-based radar signature reduction technology, marking a transition from research to a structured commercial development phase.

Adisyn managing director Arye Kohavi said the agreement upgrades a previously announced option arrangement.

“This agreement represents a critical step in transitioning our radar technology from research into commercial development,” he said.

“We have already demonstrated strong proof-of-concept results, and now, with exclusive global rights and a structured program in place, we are focused on advancing this technology towards real-world applications.

“We believe this has the potential to become a meaningful value driver alongside our core semiconductor program,” Mr Kohavi said.

The agreements provide Adisyn with long-term access to current intellectual property and its future development with defined economic terms and a clear pathway to commercialisation.

Under the agreement, Adisyn holds exclusive commercial rights across the defined field for Ramot’s IP. “We believe this has the potential to become a meaningful value driver alongside our core semiconductor program,” Mr Kohavi said.

Tel Aviv University is globally recognised for its leadership in advanced materials and applied physics, with Ramot responsible for commercialising numerous breakthrough technologies, providing Adisyn with access to world-class research capability and commercialisation expertise.

Adisyn’s technology integrates graphene and other 2D materials into composite materials to reduce radar detectability by absorbing and dissipating electromagnetic signals.

Unlike traditional materials, graphene composites combine structural performance with inherent radar absorption, removing the need for additional coatings and enabling lightweight, stealth-enabled designs.

AI1 is steady at 7.5¢ today. Mkt cap $62.55M.

Join the discussion: See what HotCopper users are saying about Adisyn Ltd and be part of the conversations that move the markets.

The material provided in this article is for information only and should not be treated as investment advice. Viewers are encouraged to conduct their own research and consult with a certified financial advisor before making any investment decisions. For full disclaimer information, please click here.

ai1 by the numbers
More From The Market Online

Listen: HotCopper Wire Podcast #047 – Maybe just send an email next time, Albo

In this week’s HotCopper Wire episode, Isaac McIntyre and Jonathon Davidson break down (poke holes in) Albo’s national address from 7PM Wednesday, talk
The Market Online Video

Introducing Prairie Lithium: Saskatchewan’s permitted lithium project ready to scale

We've spoken to Prairie Lithium founder Zach Maurer about the explorer's overall mission, right after Macquarie's…
The Market Online Video

US growth, injectable iron pipeline: How AFT Pharma is driving toward $300 million by FY27

AFT Pharmaceuticals (ASX:AFP) is in a red-hot position as we head straight into FY26’s fourth quarter in Australia, and
The Market Online graphic with ASX-branded charts and the text "HotCopper Highlights" centred in white.

HotCopper Highlights, Week 15: Santos, Karoon, Viva all riding the Iran-fuelled Energy rollercoaster

Hello, hello, and welcome to HotCopper Highlights for Week 15, CY26, I’m Isaac McIntyre.